June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Comparing Optos OTI and Heidelberg Spectralis SD-OCT in Patients with Diabetic Macular Edema
Author Affiliations & Notes
  • Samia Fatum
    Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
  • Magdalena Sinczak
    Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
  • Amun Sachdev
    Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
  • Victor Chong
    Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
  • Footnotes
    Commercial Relationships Samia Fatum, None; Magdalena Sinczak, None; Amun Sachdev, None; Victor Chong, Novartis (C), Bayer (C), Allergan (C), Pfizer (F), Novartis (F), Alimera Science (C), Quantel (R)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5870. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samia Fatum, Magdalena Sinczak, Amun Sachdev, Victor Chong; Comparing Optos OTI and Heidelberg Spectralis SD-OCT in Patients with Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5870. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Heidelberg Spectralis Spectral Domain Optical Coherent Topography (SD-OCT) is often considered the current gold standard of SD-OCT. However, it does not have the ability to measure retinal function. In a previous study, microperimetry points from another machine were overlaid onto to the SD-OCT scan. As the optics of the machines is different, it was not clear whether the point to point correlation was correct. The Optos OTI has the microperimetry in the same machine, allowing point to point co-localisation. In this study we compared the measurements of these two machines in patients with diabetic macular edema (DME).

Methods: Patients with early DME were recruited in this study. Best corrected visual acuity (BCVA) was measured by letter counting with ETDRS chart. SD-OCT was measured by Spectralis and OTI in the same setting, one after the other. The central subfield and the parafoveal subfield (3mm) were analysed and compared between the two machines. The statistical analysis was calculated with SPSS.

Results: There were 62 eyes included in the study. The mean age was 58.1 years, the mean BCVA was 77.2 letters, and the mean retinal thicknesses as measured by Spectralis were 310, 343, 344, 332, and 340 microns in the central, superior, temporal, inferior and nasal sub-field respectively, while the mean retinal thicknesses as measured by OTI were 237, 298, 297, 289, 290 microns in the central, superior, temporal, inferior and nasal sub-field respectively. The correlation of the two machines was highly significant in all five subfields (p<0.0001). The Pearson Correlations were 0.752, 0.85, 0.928, 0.839, and 0.823 in the central, superior, temporal, inferior and nasal sub-field respectively.

Conclusions: Although the absolute measurements of the two machines are significantly different, the correlation is over 75% in all sub-fields. This suggests that while it is not possible to transfer absolute measurements from one machine to the other, the OTI machine can be used for OCT measurements in patients with early DME requiring microperimetry assessment. Further studies are needed to identify the reason for these differences, which might allow us to have an even better correlation between the two machines.

Keywords: 499 diabetic retinopathy • 505 edema • 733 topography  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×